Impact Biomedical (IBO) Research & Development (2022 - 2026)
Impact Biomedical's Research & Development came in at $76,000 for Q2 2026, up 1.3% from $75,000 a year earlier and up 65.2% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Research & Development (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Impact Biomedical reported Research & Development of $249,000, up 63.8% year-over-year; for FY2024, it came in at $278,000, down 83.5% from FY2023.
- Going back by year, Research & Development was $1.69 million in FY2023 (+37.4%) and $1.23 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Research & Development since Q1 2025.
- Year-over-year, Research & Development increased in 1 of the last six quarters, with an average decline of 41.6%.
- The fastest year-over-year change in Research & Development over five years came in Q2 2023 (growth of 29.1%), and the weakest in Q3 2024 (a decline of 77.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Impact Biomedical | 598.41 Mn | 601.61 Mn | 2,000.00 | 76,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 121,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 630,000.00 |
| Sep 30, 2023 | 357,000.00 |
| Jun 30, 2023 | 266,000.00 |
| Mar 31, 2023 | 179,000.00 |
| Dec 31, 2022 | 522,000.00 |
| Sep 30, 2022 | 330,000.00 |
| Jun 30, 2022 | 206,000.00 |
API Access
Impact Biomedical Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();